STAA — STAAR Surgical Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMid CapHigh Flyer

Annual income statement for STAAR Surgical, fiscal year end - January 2nd, USD millions except per share, conversion factor applied.

	2021 December 31st	R2022 December 30th	2023 December 29th	2024 December 27th	2026 January 2nd
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	230	284	322	314	239
Cost of Revenue
Gross Profit	179	223	253	240	182
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	197	241	294	327	331
Operating Profit	33.3	43.8	28.1	-12.6	-91.7
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	31.3	45.6	33.7	-9.05	-82.3
Provision for Income Taxes
Net Income After Taxes	24.5	39.7	21.3	-20.2	-80.4
Net Income Before Extraordinary Items
Net Income	24.5	39.7	21.3	-20.2	-80.4
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	24.5	39.7	21.3	-20.2	-80.4
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.495	0.804	0.435	-0.389	-1.02